Anti-HPV16L1 [CamVir 1]
Invented at University of Cambridge
- Datasheet
- References (8)
- Inventor Info
Info
![Image thumbnail for Anti-HPV16L1 [CamVir 1]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/d41f9824-9d8b-4408-a5c0-3427b1be5f5c.jpg)
![Image thumbnail for Anti-HPV16L1 [CamVir 1]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/f0b1a998-66ba-45e6-b32a-12802a21b9a8.jpg)
![Image thumbnail for Anti-HPV16L1 [CamVir 1]](https://res.cloudinary.com/ximbio/image/upload/c_fit,fl_lossy,h_45,q_auto/6883a3e3-d28f-4e67-a4fd-ef524206275a.jpg)
| Catalogue Number | 151084 |
| Applications | ELISA IHC IP WB |
| Antigen/Gene or Protein Targets | Human papilloma virus type 16, major capsid protein L1 (HPV16 L1) |
| Reactivity | Human papilloma virus |
| Relevance | The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases, and HPV-1, which is associated with benign cutaneous warts. HPV late protein L1 is the major capsid protein. |
| Host | Mouse |
| Immunogen | A b galactosidase-L1 fusion protein purified by PAGE. |
| Subclass | IgG2a |
| Molecular Weight (kDa) | 56 |
| Myeloma Used | NS0 |
| Recommended Growing Conditions | DMEM + 5% FCS |
| Notes | CamVir-1 reacts very strongly with biopsy specimens containing HPV-16 or HPV-33, but very weak reactions were occasionally observed with biopsy specimens or smears containing HPV-6 or HPV-11. |
| Research Area | Cancer, Virology |
References: 8 entries
Day et al. 2012. Clin Vaccine Immunol. 19(7):1075-82. PMID: 22593236.
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
Europe PMC ID: 22593236
Steele et al. 2005. Br J Cancer. 93(2):248-59. PMID: 15986031.
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.
Europe PMC ID: 15986031
Zhang et al. 1998. Virology. 243(2):423-31. PMID: 9568041.
Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
Europe PMC ID: 9568041
McLean et al. 1990. J Clin Pathol. 43(6):488-92. PMID: 2166093.
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.
Europe PMC ID: 2166093
Add a reference
References: 8 entries
Day et al. 2012. Clin Vaccine Immunol. 19(7):1075-82. PMID: 22593236.
A human papillomavirus (HPV) in vitro neutralization assay that recapitulates the in vitro process of infection provides a sensitive measure of HPV L2 infection-inhibiting antibodies.
Steele et al. 2005. Br J Cancer. 93(2):248-59. PMID: 15986031.
T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia.
Zhang et al. 1998. Virology. 243(2):423-31. PMID: 9568041.
Expression of human papillomavirus type 16 L1 protein in Escherichia coli: denaturation, renaturation, and self-assembly of virus-like particles in vitro.
McLean et al. 1990. J Clin Pathol. 43(6):488-92. PMID: 2166093.
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus.
Add a reference
